Evidence map›Paper›PMID 23132172›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

A dual point-of-care test shows good performance in simultaneously detecting nontreponemal and treponemal antibodies in patients with syphilis: a multisite evaluation study in China.

Yue-Ping Yin, Xiang-Sheng Chen, Wan-Hui Wei, Kuang-Long Gong, Wen-Ling Cao, Gang Yong, Liang Feng, Shu-Jie Huang, Dong-Mei Wang, Yan Han and 3 more

Abstract readEvaluation StudyMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Metaanalysis of the Performance of a Combined Treponemal and Nontreponemal Rapid Diagnostic Test for Syphilis and Yaws.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Pooled it
  4. Trial
  5. Article
  6. Review
  7. Laboratory Evaluation of the Chembio DPP Syphilis Screen & Confirm Point-of-Care Test on Serum and Simulated Blood Samples.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Nanotechnology in reproductive medicine: Opportunities for clinical translation.Clinical and experimental reproductive medicine · 2020
    Article
  14. Syphilis Self-testing: A Nationwide Pragmatic Study Among Men Who Have Sex With Men in China.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Syphilis.Nature reviews. Disease primers · 2017
    Review
  19. Syphilis: Re-emergence of an old foe.Microbial cell (Graz, Austria) · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yue-Ping YinNational Center for STD Control, China Center for Disease Control and Prevention.
Xiang-Sheng Chen
Wan-Hui Wei
Kuang-Long Gong
Wen-Ling Cao
Gang Yong
Liang Feng
Shu-Jie Huang
Dong-Mei Wang
Yan Han
Shao-Chun Chen
David Mabey
Rosanna W Peeling

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRapid point-of-care (POC) syphilis tests based on simultaneous detection of treponemal and nontreponemal antibodies (dual POC tests) offer the opportunity to increase coverage of syphilis screening and treatment. This study aimed to conduct a multisite performance evaluation of a dual POC syphilis test in China.

methodsParticipants were recruited from patients at sexually transmitted infection clinics and high-risk groups in outreach settings in 6 sites in China. Three kinds of specimens (whole blood [WB], fingerprick blood [FB], and blood plasma [BP]) were used for evaluating sensitivity and specificity of the Dual Path Platform (DPP) Syphilis Screen and Confirm test using its treponemal and nontreponemal lines to compare Treponema pallidum particle agglutination (TPPA) assay and toluidine red unheated serum test (TRUST) as reference standards.

resultsA total of 3134 specimens (WB 1323, FB 488, and BP 1323) from 1323 individuals were collected. The sensitivities as compared with TPPA were 96.7% for WB, 96.4% for FB, and 94.6% for BP, and the specificities were 99.3%, 99.1%, and 99.6%, respectively. The sensitivities as compared with TRUST were 87.2% for WB, 85.8% for FB, and 88.4% for BP, and the specificities were 94.4%, 96.1%, and 95.0%, respectively. For specimens with a TRUST titer of 1:4 or higher, the sensitivities were 100.0% for WB, 97.8% for FB, and 99.6% for BP.

conclusionsDPP test shows good sensitivity and specificity in detecting treponemal and nontreponemal antibodies in 3 kinds of specimens. It is hoped that this assay can be considered as an alternative in the diagnosis of syphilis, particularly in resource-limited areas.

Indexed as

Point-of-Care SystemsAdolescentAdultAgedAged, 80 and overAgglutination TestsAntibodies, BacterialChinaFemaleHumansMaleMiddle AgedPredictive Value of TestsSensitivity and SpecificitySyphilisSyphilis SerodiagnosisAntibodies, Bacterial

Identifiers

PMID23132172
PMCPMC3657488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.